REQUEST A DEMO
Total
USD $0.00
Search more companies

BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: BioGend Therapeutics Co., Ltd. Profile Updated: January 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) is a company based in Taiwan, China, with its head office in Taipei City. The enterprise currently operates in the Pharmaceutical and Medicine Manufacturing sector. The enterprise was incorporated on July 07, 2016. 28 (2023) employees currently work for BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司). In Q3C2025, the company reported a net sales revenue increase of 38.25%. Over the same period, its total assets decreased by 10.92%. In 2025, BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司)’s net profit margin increased by 31.83%.

Headquarters
4F, No.3-2, Yuang St.Nangang District
Taipei City; Taipei City;

Contact Details: Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.

Website: http://www.biogend.com.tw

Basic Information
Total Employees:
Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.
Outstanding Shares:
Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.
Financial Auditors:
Purchase the BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report to view the information.
Incorporation Date:
July 07, 2016
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
30.24%
Purchase this report to view the information.
3.05%
Purchase this report to view the information.
2.26%
Purchase this report to view the information.
1.61%
Purchase this report to view the information.
1.35%
Subsidiaries
山東博升生物技術有限公司
100%
Osteopharma Inc. (Japan)
46.73%
Company Performance
Financial values in the chart are available after BioGend Therapeutics Co., Ltd. (博晟生医股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
38.25%
Total operating revenue
38.44%
Operating Profit/Loss (EBIT)
17.49%
EBITDA
24.56%
Net Profit/Loss for the Period
19.64%
Total Assets
-10.92%
Total Equity
-11.09%
Operating Profit Margin (ROS)
34.31%
Net Profit Margin
31.83%
Return on Equity (ROE)
0.98%
Debt/Equity
-0.33%
Quick Ratio
-6.62%
Cash Ratio
1.98%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?